Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2288
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion ; volume:14 ; number:1 ; day:22 ; month:12 ; year:2014 ; pages:1-13 ; date:12.2014
BMC medical research methodology ; 14, Heft 1 (22.12.2014), 1-13, 12.2014
- Urheber
-
Thom, Howard HZ
- Beteiligte Personen und Organisationen
-
Capkun, Gorana
Nixon, Richard M.
Ferreira, Alberto
SpringerLink (Online service)
- DOI
-
10.1186/1471-2288-14-140
- URN
-
urn:nbn:de:1111-2016032137428
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thom, Howard HZ
- Capkun, Gorana
- Nixon, Richard M.
- Ferreira, Alberto
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Ranibizumab Pro Re nata versus Dexamethasone in the management of ischemic retinal vein occlusion: post-hoc analysis from the COMRADE trials
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Oedema.
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Oedema. - Hernia.
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Ranibizumab Pro Re nata versus Dexamethasone in the management of ischemic retinal vein occlusion: post-hoc analysis from the COMRADE trials
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Oedema.
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Oedema. - Hernia.
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Ranibizumab Pro Re nata versus Dexamethasone in the management of ischemic retinal vein occlusion: post-hoc analysis from the COMRADE trials
Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
Disease-modifying effects of ranibizumab for central retinal vein occlusion
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Oedema.
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
Oedema. - Hernia.